Conflict of interest: Dr. Mehran reports institutional research grant support from Bristol-Myers Squibb/Sanofi-Aventis and The Medicines Company and consulting agreements with Abbott Vascular, AstraZeneca, Regado Biosciences, and OrthoMcNeil.
Coronary Artery Disease
The optimal approach to coronary bifurcations: Systematic rather than simplified?†
Article first published online: 17 FEB 2012
Copyright © 2012 Wiley Periodicals, Inc.
Catheterization and Cardiovascular Interventions
Volume 79, Issue 4, pages 623–624, 1 March 2012
How to Cite
Sergie, Z. and Mehran, R. (2012), The optimal approach to coronary bifurcations: Systematic rather than simplified?. Cathet. Cardiovasc. Intervent., 79: 623–624. doi: 10.1002/ccd.24318
- Issue published online: 17 FEB 2012
- Article first published online: 17 FEB 2012
- Manuscript Received: 5 JAN 2012
- Manuscript Accepted: 5 JAN 2012